Skip to content

Press Release

Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale

Cambridge, UK, 25 January 2024: Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies, today announced the appointment of Peter Crossley as Chief Operating Officer (COO). With 27 years’ experience in novel technology and product development, Peter will bolster Cellular Origins’ mission to develop scalable automation solutions for cell therapy manufacture that will improve patient access to these potentially life-saving treatments.

In the new role, Peter will lead the ongoing development and delivery of Cellular Origins’ products by driving team growth and overseeing people development.

Peter has been instrumental in the delivery of ground-breaking life science products sold worldwide, and the invention and delivery of highly complex, novel manufacturing systems. He has worked as a Consultant at TTP for the past 17 years, and played a key role in growing TTP’s life science business. He was most recently interim CTO at Depixus. With a BEng in Aerospace Engineering from the University of Bristol, Peter began his career in gas turbine development at Rolls-Royce, before moving to R&D and technical management in consumer products at Dyson and Fisher & Paykel.

See more on Cellular Origins’ senior team here,

Peter Crossley, COO at Cellular Origins, said: “Cellular Origins is in an exciting phase of growth. As COO, I look forward to driving the expansion of Cellular Origins’ world-class team, as well as supporting them to bring about a revolution in cell therapy manufacture that will deliver these life changing treatments to all who need them.”

Dr Edwin Stone, CEO at Cellular Origins, added: “I am delighted to welcome Peter. His proven cross-sector experience, leadership skills, and ability to turn ground-breaking innovation into commercial reality will accelerate our mission to develop scalable automation solutions for cell therapies.”

To learn more about career opportunities at Cellular Origins, please visit

Peter Crossley, COO of Cellular Origins

About Cellular Origins  

Cellular Origins, a TTP Company, is focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies. 

Despite the incredible potential for cell and gene therapies in the treatment of disease, emerging therapies are inaccessible to patients due to insufficient expertise and manufacturing capability for affordable production. With an increasing number of approved cell and gene therapies currently reaching the market, the disconnect between innovative therapies and manufacturing capabilities has led to an urgent need for solutions that provide large-scale access to cost-effective, next-generation therapeutics. 

Created to provide therapeutic developers access to the equipment they want, at the scale they need, Cellular Origins’ proprietary technology provides a transformative solution for automated, sterile, fluidic interconnection, to enable cell and gene therapy manufacturing at scale. Cellular Origins technology has been carefully designed to integrate into existing workflows, alleviating the need for process redevelopment, without constraining process innovation.  

TTP has more than 30 years’ experience in supporting the world’s most innovative and ambitious organisations develop new tools and technologies, from creating the first highly scaled out roller bottle manufacturing platform for Amgen to creating new bioprocess tools companies such as TAP Biosystems. Bringing together expertise from across the life science, engineering, and robotics industries, Cellular Origins is focused on enabling developers to accelerate their therapeutics to market.  

To find out more about Cellular Origins and its innovative cell therapy manufacture solutions, please visit Follow Cellular Origins on X (@CellularOrigins) and LinkedIn (@CellularOrigins). 

For further information please contact:

As featured in: